- NCIt
- C3613
Loading cancer entity…
Loading cancer entity…
Clinical trials
65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04879940 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | active not recruiting | Phase 2 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06161506 | Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer | recruiting | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2026 | clinicaltrials |
| NCT04693507 | Teverelix Evaluated in Advanced Prostate Cancer(TEACh) | completed | Phase 2 | 50 | Antev Ltd.INDUSTRY | 1 | Jul 23, 2024 | clinicaltrials |
| NCT00596011 | Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia |
Data updated 22 days agoSource updated Jul 30, 2026source: clinicaltrials
| completed |
| Phase 2 |
| 97 |
| H. Lee Moffitt Cancer Center and Research InstituteOTHER |
| 1 |
| Oct 4, 2019 |
| clinicaltrials |
| NCT03600766 | Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study | unknown | Phase 2 | 50 | Mansoura UniversityOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01678313 | Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels | completed | Phase 2 | 140 | Buddhist Tzu Chi General HospitalOTHER | 1 | Jul 15, 2014 | clinicaltrials |
| NCT01218243 | An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia | completed | Phase 2 | 100 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | May 27, 2013 | clinicaltrials |